Frog Bacteria Kills Cancer. A Single Dose. 100% Cure. No Recurrence.

by | Jul 23, 2026 | Articles, Cancer, FDA and Government, Government and FDA, Latest News | 0 comments

Frog Bacteria Kills Cancer. A Single Dose. 100% Cure. No Recurrence.

Frog Bacteria Kills Cancer. A Single Dose. 100% Cure. No Recurrence.

What if the cure for cancer wasn’t created in a multi-billion dollar pharmaceutical lab, but was discovered hiding inside the gut of a Japanese tree frog?

A groundbreaking, peer-reviewed study published in Gut Microbes by researchers at the Japan Advanced Institute of Science and Technology (JAIST) has sent shockwaves through the oncology world. A specific strain of bacteria, Ewingella americana, isolated from the Japanese tree frog (Dryophytes japonicus), completely eradicated colorectal tumors in mice after a single intravenous dose. [1]

The results were unprecedented: a 100% complete response rate in the primary study group. When the researchers attempted to re-inject the cured mice with the same cancer cells 30 days later, the tumors failed to grow. The bacteria hadn’t just killed the cancer; it had trained the immune system to remember and destroy it. [2]

The Dual Mechanism: How Ewingella Americana Destroys Tumors

Cancer cells are notorious for evading the immune system and creating “hypoxic” (low oxygen) environments where normal immune cells struggle to survive. But what is toxic to human immune cells is a paradise for certain bacteria.

The JAIST researchers discovered that E. americana attacks tumors through two independent, devastating pathways:

Dual Mechanism of Ewingella Americana
The dual mechanism: Direct cytotoxicity and systemic immune activation.

1. Direct Cytotoxicity (Tumor Lysis)
Because E. americana is a facultative anaerobe, it thrives in the low-oxygen core of solid tumors. After intravenous injection, the bacteria preferentially accumulated inside the tumor, multiplying 3,000-fold within 24 hours. Once inside, the bacteria release cytolysins and exotoxins that directly tear the cancer cells apart from the inside out. [1]

2. Massive Immune Activation
As the bacteria rip the tumor cells apart, they spill hidden cancer antigens into the bloodstream. Simultaneously, the presence of the bacteria triggers a massive immune alarm. The study documented a 30% increase in neutrophils, alongside significant spikes in T-cells, B-cells, and tumor-destroying cytokines like TNF-alpha and interferon-gamma. The immune system wakes up, sees the exposed cancer antigens, and finishes the job. [1]

The 100% Complete Response: Unpacking the Data

The researchers tested the frog bacteria against traditional chemotherapy (liposomal doxorubicin) and modern immunotherapy (anti-PD-L1 antibodies) in mice with established Colon-26 tumors.

Study Results and Data
Study design, treatment groups, and complete response rates.

The results were stark:

  • Liposomal doxorubicin: 0 out of 5 complete responses
  • Anti-PD-L1: 1 out of 5 complete responses
  • Ewingella americana: 5 out of 5 complete responses (100%)

While this is a small preclinical mouse study and not yet ready for human trials, the complete eradication of established tumors from a single dose represents a massive leap forward in bio-oncology. [3]

Why Static Frequencies Fail: The End of the “Rife” Era

As we look at advanced bioelectric and bacterial therapies, we must address a persistent myth in the alternative health community: the “Rife Frequency” lists.

Many people suffering from cancer purchase single-frequency generators, hoping to dial in a specific “Rife frequency” (like 2127 Hz) to destroy their tumors. This is biologically flawed and historically inaccurate.

Dr. Royal Rife never published a list of static frequencies. The lists circulating online today were fabricated decades later, mostly in the 1990s. More importantly, bombarding a tumor with a single, static frequency ignores the reality of cellular biology: Cellular Adaptation.

Just as bacteria mutate to resist antibiotics, cancer cells rapidly adapt to static electromagnetic fields. If you play the exact same frequency into a tumor day after day, the cancer cells will adjust their membrane potential and ignore the signal within 3 to 7 days. You are effectively vaccinating the tumor against the therapy.

The Solution: Multi-Phase BioPhi-Harmonic Architecture

To overcome cellular adaptation, modern frequency medicine must mimic the complexity of the body itself. This requires Multi-Phase Architecture—programs that dynamically shift through different frequencies, waveforms, and harmonics to prevent the cancer cells from adapting, while simultaneously supporting immune function and lymphatic drainage.

This is delivered through a Triple Modality Protocol:

Triple Modality PEMF Protocol
The synergistic triple-modality approach to frequency delivery.

1. Haptic Delivery (Woojer Vest): Low-frequency vibrations delivered directly into the skeletal structure and deep organ tissue, bypassing the ears entirely. This activates the nervous system and creates physical cellular resonance.

2. PEMF Delivery (iTorus): Pulsed electromagnetic fields that penetrate the entire body, restoring the voltage of healthy cell membranes (which operate at -70mV to -90mV) while disrupting the low-voltage environment of tumor cells (which operate around -15mV).

3. Binaural 3D Audio: Spatial soundscapes that entrain the brain into deep Delta and Theta states, forcing the nervous system out of “fight or flight” (sympathetic) and into the “rest and repair” (parasympathetic) state required for immune activation.

Advanced ePEMF Programs for Cellular Support

For those utilizing the triple-modality approach, the following multi-phase programs from the ePEMF app are engineered to support the body’s natural immune defenses and cellular resonance without triggering adaptation.

Required Hardware for the Triple Modality Protocol

To execute these multi-phase protocols effectively, you must combine the frequencies with the correct delivery hardware. Playing these through standard iPhone speakers will not penetrate the cellular matrix.

Device Modality Primary Function Official Link
iTorus i2 PEMF Targeted, portable pulsed electromagnetic field delivery for localized cellular voltage repair. View iTorus i2
iTorus i5 PEMF High-power, full-room electromagnetic field generation for systemic, whole-body saturation. View iTorus i5
Woojer Vest 4 Haptic Delivers frequencies as physical vibroacoustic waves directly into the skeletal structure and organs. View Woojer Vest
iMPrinter Energetic Transfers the energetic signatures of multi-phase programs into water or carrier oils for internal consumption. View iMPrinter

The Future of Bio-Oncology

Whether it is the physical disruption of a tumor via Ewingella americana bacteria, or the bioelectric disruption of a tumor via multi-phase PEMF protocols, the future of cancer research is moving away from toxic, systemic chemicals and toward targeted, resonant, biological disruption.

The frog bacteria study proves that the body’s immune system can achieve a 100% complete response when given the right trigger. Our goal with frequency medicine is to provide that trigger bioelectrically.

References

  1. Iwata S, Yamasita N, Asukabe K, Sakari M, Miyako E. “Discovery and characterization of antitumor gut microbiota from amphibians and reptiles: Ewingella americana as a novel therapeutic agent with dual cytotoxic and immunomodulatory properties.” Gut Microbes. 2025;17(1):2599562. PMCID: PMC12710904
  2. DOI: 10.1080/19490976.2025.2599562
  3. PubMed: PMID: 41376334
  4. The Truth About Cancer Official Substack: CANCER: The Frog, the Bacteria, and the Big Pharma Patent Portfolio

Related Articles